Videos

CEO Dave Lareau explains how Medicomp made early coronavirus-specific changes to its database and AI engine as the pandemic took hold in February – and has continued to innovate since then.

Dr. Nathalie Bloch of the ARC Innovation Center at Sheba Medical Center, Israel, discusses the use of AI in dealing with COVID-19 patients, among various other innovative tools, in this episode of The Alessi Agenda.

Amwell President and CEO Dr. Roy Schoenberg describes how the public health crisis is impacting his telehealth company and is rewriting the expectations for virtual care.

In this episode of The Alessi Agenda, Woodlands Health Campus CEO Dr. Jason Cheah discusses how global examples of EMRs, robotics and telehealth helped shape the digital transformation and patient journey in Singapore.

Kuldeep Singh Rajput, CEO and founder of Biofourmis, discusses using remote monitoring tech to reach patients at home and reduce contact with COVID-19-positive patients.

2bPrecise CMO Joel Diamond, MD, says pharmacogenomics is a good entry point for providers in precision medicine, identifying the right medicine for better outcomes and patient satisfaction.

Lyniate Chief Product and Strategy Officer Drew Ivan and Life Image CEO Matthew Michela discuss how technology issues for interoperability are more of a cultural than a deployment challenge.

With consumer-centric healthcare, patients have access to their cost and data and, in a post-COVID world, more virtual care.

HIMSS Director of Privacy and Security Lee Kim offers insights for health systems as they defend against both COVID-19 and the opportunistic cyberattacks that are using it as cover to sow chaos.

The 72-practice Community Care Physicians medical group turns to patient engagement technology to improve its no-show rate, send COVID-related newsletters to patients and remind them of their telehealth appointments during the pandemic.